138 related articles for article (PubMed ID: 3806607)
1. Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists.
Musser JH; Chakraborty UR; Sciortino S; Gordon RJ; Khandwala A; Neiss ES; Pruss TP; Van Inwegen R; Weinryb I; Coutts SM
J Med Chem; 1987 Jan; 30(1):96-104. PubMed ID: 3806607
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitors.
Musser JH; Kubrak DM; Chang J; Lewis AJ
J Med Chem; 1986 Aug; 29(8):1429-35. PubMed ID: 3090264
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene D4 antagonists and 5-lipoxygenase inhibitors. Synthesis of benzoheterocyclic [(methoxyphenyl)amino]oxoalkanoic acid esters.
Musser JH; Kubrak DM; Chang J; DiZio SM; Hite M; Hand JM; Lewis AJ
J Med Chem; 1987 Feb; 30(2):400-5. PubMed ID: 3806620
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiallergic activity of a novel series of 5-lipoxygenase inhibitors.
Kees KL; Musser JH; Chang J; Skowronek M; Lewis AJ
J Med Chem; 1986 Nov; 29(11):2329-34. PubMed ID: 2878078
[TBL] [Abstract][Full Text] [Related]
5. Substituted (aryloxy)alkanoic acids as antagonists of slow-reacting substance of anaphylaxis.
LeMahieu RA; Carson M; Han RJ; Nason WC; O'Donnell M; Brown DL; Crowley HJ; Welton AF
J Med Chem; 1987 Jan; 30(1):173-8. PubMed ID: 3027332
[TBL] [Abstract][Full Text] [Related]
6. Novel 1,3-bis(aryloxy)propanes as leukotriene D4 antagonists.
Kreft AF; Klaubert DH; Bell SC; Pattison TW; Yardley JP; Carlson RP; Hand JM; Chang JY; Lewis AJ
J Med Chem; 1986 Jul; 29(7):1134-8. PubMed ID: 3806566
[TBL] [Abstract][Full Text] [Related]
7. N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure.
Musser JH; Kreft AF; Bender RH; Kubrak DM; Grimes D; Carlson RP; Hand JM; Chang J
J Med Chem; 1990 Jan; 33(1):240-5. PubMed ID: 2104935
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mammalian 5-lipoxygenase by 2-benzylaminophenols.
Buckle DR; Bumstead J; Clarke GD; Foster KA; Parr H; Taylor JF; Thody VE; Webster RA
Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):29-33. PubMed ID: 3186776
[TBL] [Abstract][Full Text] [Related]
9. Effect of structure on potency and selectivity in 2,6-disubstituted 4-(2-arylethenyl)phenol lipoxygenase inhibitors.
Lazer ES; Wong HC; Wegner CD; Graham AG; Farina PR
J Med Chem; 1990 Jul; 33(7):1892-8. PubMed ID: 2113949
[TBL] [Abstract][Full Text] [Related]
10. The development of new antileukotriene drugs: specific leukotriene D4 antagonists and 5-lipoxygenase inhibitors.
Rokach J; Young RN
Adv Exp Med Biol; 1989; 259():75-108. PubMed ID: 2560345
[No Abstract] [Full Text] [Related]
11. The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses.
Bhattacherjee P; Boughton-Smith NK; Follenfant RL; Garland LG; Higgs GA; Hodson HF; Islip PJ; Jackson WP; Moncada S; Payne AN
Ann N Y Acad Sci; 1988; 524():307-20. PubMed ID: 2837965
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 2. Effects of an additional phenyl ring on receptor affinity.
Huang FC; Galemmo RA; Johnson WH; Poli GB; Morrissette MM; Mencel JJ; Warus JD; Campbell HF; Nuss GW; Carnathan GW
J Med Chem; 1990 Apr; 33(4):1194-200. PubMed ID: 2157010
[TBL] [Abstract][Full Text] [Related]
13. The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice.
Rainsford KD
Agents Actions; 1987 Aug; 21(3-4):316-9. PubMed ID: 3687587
[No Abstract] [Full Text] [Related]
14. N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structure.
Musser JH; Kreft AF; Bender RH; Kubrak DM; Carlson RP; Chang J; Hand JM
J Med Chem; 1989 Jun; 32(6):1176-83. PubMed ID: 2498516
[TBL] [Abstract][Full Text] [Related]
15. Novel 1H-benzimidazol-4-ols with potent 5-lipoxygenase inhibitory activity.
Buckle DR; Foster KA; Taylor JF; Tedder JM; Thody VE; Webster RA; Bermudez J; Markwell RE; Smith SA
J Med Chem; 1987 Dec; 30(12):2216-21. PubMed ID: 3681891
[TBL] [Abstract][Full Text] [Related]
16. 2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis.
Yoshimoto T; Yokoyama C; Ochi K; Yamamoto S; Maki Y; Ashida Y; Terao S; Shiraishi M
Biochim Biophys Acta; 1982 Nov; 713(2):470-3. PubMed ID: 6817808
[TBL] [Abstract][Full Text] [Related]
17. In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase.
Summers JB; Gunn BP; Mazdiyasni H; Goetze AM; Young PR; Bouska JB; Dyer RD; Brooks DW; Carter GW
J Med Chem; 1987 Nov; 30(11):2121-6. PubMed ID: 3669019
[TBL] [Abstract][Full Text] [Related]
18. Preferential inhibition of 5-lipoxygenase activity by manoalide.
De Vries GW; Amdahl L; Mobasser A; Wenzel M; Wheeler LA
Biochem Pharmacol; 1988 Aug; 37(15):2899-905. PubMed ID: 2840081
[TBL] [Abstract][Full Text] [Related]
19. Arachidonate 5-lipoxygenase and its new inhibitors.
Yamamoto S; Yoshimoto T; Furukawa M; Horie T; Watanabe-Kohno S
J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 2):349-52. PubMed ID: 6432877
[TBL] [Abstract][Full Text] [Related]
20. Antagonists of slow-reacting substance of anaphylaxis. 1. Pyrido[2,1-b]quinazolinecarboxylic acid derivatives.
Tilley JW; Levitan P; Welton AF; Crowley HJ
J Med Chem; 1983 Nov; 26(11):1638-42. PubMed ID: 6313920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
